Quetiapine Fumarate Extended‐Release for the Treatment of Major Depression With Comorbid Fibromyalgia Syndrome: A Double‐Blind, Randomized, Placebo‐Controlled Study

McIntyre, Alexander; Paisley, David; Kouassi, Édouard; Gendron, Alain

doi:10.1002/art.38228

Public

Quetiapine Fumarate Extended‐Release for the Treatment of Major Depression With Comorbid Fibromyalgia Syndrome: A Double‐Blind, Randomized, Placebo‐Controlled Study

Published in Arthritis & Rheumatology • Oct 21, 2013

Authors:

Alexander McIntyre

David Paisley

Édouard Kouassi

Abstract

OBJECTIVE: Fibromyalgia and major depressive disorder (MDD) frequently co-occur. Quetiapine fumarate extended-release (quetiapine XR) has demonstrated efficacy in the treatment of MDD and has been shown to have analgesic properties in patients with depression. The primary objectives of this study we...

Subject

Quetiapine

Fibromyalgia

Tolerability

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!